Abstract. In Niemann-Pick Type C (NPC) disease, the concentration of cholesterol increases with age in every tissue except the brain. This study investigates whether accumulation of cholesterol might also occur within the cells of the central nervous system (CNS), but be obscured by the simultaneous loss of sterol from myelin as neurodegeneration proceeds. At birth, when there is little myelin in the CNS, the concentration of cholesterol is significantly elevated in every region of the brain in the homozygous NPC mouse. At 7 wk of age, myelination is nearly complete. In the NPC mouse, however, there is striking neurodegeneration and a reduction in both myelin protein and myelin cholesterol. Furthermore, net loss of cholesterol from the CNS is much higher in the NPC mouse than in the control animal (2.23 versus 1.37 mg/day per kg) so that the concentration of sterol in most regions of the brain is reduced. This neurodegeneration and loss of myelin cholesterol is not prevented by deletion of either the low-density lipoprotein receptor or apolipoprotein E in the NPC animal. Thus, the cholesterol sequestration seen in every organ in NPC disease also occurs in cells of the CNS and may be etiologically related to the neurodegeneration.
INTRODUCTION
Niemann-Pick Type C (NPC) disease in either humans or mice is characterized by organomegaly at birth, liver function abnormalities, and the development of progressive neurodegeneration with loss of myelin from some regions of the central nervous system (CNS) (1) (2) (3) (4) . The classical presentation of this disease in humans typically involves a transient period of neonatal jaundice followed by apparent normal development in early childhood. However, behavioral abnormalities, ataxia, difficulties in vertical gaze, and a variety of other neurological dysfunctions become manifest later in childhood, and these signs of progressive neurodegeneration continuously worsen until the child becomes physically and intellectually disabled. There is considerable variation in this typical phenotype, however. Some children have much more severe liver disease with marked hepatomegaly, prolonged jaundice, ascites, and portal hypertension. Other individuals, by contrast, do not manifest either the hepatic or neurological symptoms until much later in life (3, 4) .
Recent studies have established that the mutations causing this disease in both humans and mice affect a protein designated NPC1 that is involved in the movement of cholesterol, and, possibly, other lipids, from late endosomes and lysosomes to a pool of metabolically active sterol that can be used for the formation of other products or for secretion from the cell (5) (6) (7) (8) (9) (10) (11) (12) . Thus, the classical biochemical finding in the mouse homozygous for this mutation is the time-dependent accumulation of unesterified cholesterol in nearly every organ so that, by 7 wk of age, the whole-animal pool of sterol is increased 2.5-fold (ϳ5,400 mg/kg body weight) above that found in unaffected animals (ϳ2,200 mg/kg) (13) . Every organ, except the CNS, participates in this sequestration of cholesterol although the relative increase in sterol concentration varies from ϳ10-fold in liver to only ϳ1.3-fold in tissues like striated muscle (13) . The exception to this observation is the CNS where there is a significant reduction in the pool of unesterified cholesterol in the homozygous NPC mouse (253 mg/kg) compared to control animals (305 mg/kg) (13) . A similar reduction in the concentration of cholesterol in the brains of humans with this disease has also been described (3, 14) .
The cellular pathway responsible for this sequestration of unesterified cholesterol is now fairly well understood. NPC1 apparently is involved in the intracellular movement of sterol that enters cells through the clathrin-coated-pit pathway (6, 10, 11, 15) . Low-density lipoprotein receptors (LDLR) clustered in these coated pits bind lipoproteins containing either of 2 ligands: apolipoprotein B-100 (apoB-100), that is contained in circulating lowdensity lipoproteins (LDL), and apolipoprotein E (apoE), that directs chylomicron remnants (CMr) to the liver (16) (17) (18) (19) . These particles are endocytosed, the vesicles are acidified, and an acid hydrolase hydrolyzes sterol esters to unesterified cholesterol (20, 21) . In some manner that is still poorly understood, NPC1 is responsible for moving this unesterified cholesterol to other metabolically active areas of the cell for further processing or secretion (11, (22) (23) (24) (25) (26) . The pattern of cholesterol sequestration in different organs, therefore, reflects the importance of each of these tissues in the clearance of cholesterol carried in LDL (LDL-C) and CMr (CMr-C) from the plasma (13) .
However, most of the net movement of cholesterol through the tissues of the body does not utilize this coated-pit pathway. The majority of such sterol is synthesized de novo in the extrahepatic organs, transported to the plasma membrane of the cells of these tissues, and then transferred to high-density lipoproteins (HDL-C) and esterified by the enzyme lecithin:cholesterol acyltransferase (27) (28) (29) . This cholesteryl ester is selectively taken up by the endocrine tissues and liver using a class B, type I scavenger receptor (SR-BI) and then either metabolized to steroid hormones or excreted as biliary cholesterol and bile acids (30) (31) (32) (33) . In contrast to the coated-pit pathway, this movement of newly synthesized cholesterol to the plasma membrane and through the HDL/SR-BI pathway appears to be fully functional in NPC disease and may explain why development of the fetus and newborn takes place essentially normally in this disease (34) . Presumably, abnormalities in organs like the liver and spleen become clinically evident only as cholesterol begins to cycle through the coated-pit pathway late in fetal development and during the neonatal period.
As neurodegeneration is such a key feature of the clinical syndrome of NPC disease, it is important to elucidate whether these same transport processes also regulate cholesterol balance across the cells of the CNS and whether this same sequestration of cholesterol takes place in neurons when NPC1 is mutated. Several studies have demonstrated that all, or nearly all, of the cholesterol necessary for development of the brain and spinal cord comes from synthesis in situ (35) (36) (37) (38) (39) (40) . There is currently no evidence for the movement of LDL-C or HDL-C from the plasma into the CNS (41) . Other studies, however, suggest that during nerve growth and repair the axon may utilize an extracellular source of lipoprotein cholesterol (42) . While the CNS does not contain apoB-100, several different cell types synthesize apoE, and neurons express LDLR as well as other members of the LDL receptor gene family (43) (44) (45) . The possibility exists, therefore, that during neuron growth and remodeling there is movement of cholesterol into these cells through a coated-pit pathway, and such sterol may become sequestered in the cells of the CNS in NPC disease. However, proving this possibility is difficult since the CNS is the only organ in the body that normally has 2 different pools of unesterified cholesterol, i.e. the sterol present in the plasma membranes of the neurons and support cells (3-4 mg/g) and the sterol packed into the myelin sheaths formed by oligodendrocytes (20-40 mg/g). If cholesterol does accumulate in neurons causing cell death with loss of myelin, then the net effect might be a decrease in the overall concentration of cholesterol in the CNS. Thus, these studies were undertaken in the homozygous NPC mouse for several reasons: 1) to determine if cholesterol does, in fact, accumulate in the cells of the CNS; 2) to establish whether the fall in the concentration of sterol in the whole brain with aging is due to the loss of myelin-associated cholesterol; and 3) to examine whether deletion of LDLR activity or apoE prevents the neurodegeneration and loss of myelin sterol typical of NPC disease.
MATERIALS AND METHODS

Animals and Diet
Heterozygous NPC mice (NPC ϩ/Ϫ ) with a BALB/c background were bred with each other or with homozygous LDLR knockout (LDLR Ϫ/Ϫ ) or homozygous apoE knockout (apoE Ϫ/Ϫ ) animals (15, 46) . From these crosses, 4 groups of mice were ultimately derived and these included mice that were control animals (NPC ϩ/ϩ ) or were homozygous for loss of NPC1 function (NPC Ϫ/Ϫ ). In addition, mice were generated that were homozygous for deletion of both NPC1 and LDLR activity (NPC Ϫ/ Ϫ /LDLR Ϫ/Ϫ ) or NPC1 activity and apoE (NPC Ϫ/Ϫ /apoE Ϫ/Ϫ ). The genotypes of the NPC and LDLR animals were identified using PCR protocols, and the genotype of the apoE animals was determined by Western blot analysis (8, 13, 46, 47) . After weaning, these animals were housed in groups in plastic colony cages in rooms with alternating 12-h periods of light and dark. Since no gender differences exist in the parameters studied in these experiments, the experimental groups contained equal numbers of males and females. All animals were fed ad libitum a low-cholesterol, pelleted basal rodent diet (No. 7001, Harlan Teklad, Madison, WI) that contained 0.016% (wt/wt) cholesterol and 5% (wt/wt) total lipid. All studies were carried out in the fed state during the final hour of the dark phase of the light cycle. In most experiments, animals were studied at 7 wk of age. In 1 experiment, cholesterol concentrations were measured in both 1-day-old and 7-wk-old mice. In another study, wholebrain cholesterol concentrations were determined in animals at ages varying from 1 day to 10 wk. All experimental protocols were approved by the Institutional Animal Care and Research Advisory Committee.
Tissue Cholesterol Concentration
Animals were exsanguinated from the inferior vena cava and the major tissues were removed, weighed, and saponified (40) . The remaining carcass, composed mainly of skeleton, muscle, and adipose tissue, was also saponified. The cholesterol concentration in these tissue samples was measured by gas-liquid chromatography and expressed as mg of cholesterol per g wet weight of tissue (mg/g) (48) . For measurement of the total cholesterol pool in brain and the whole animal, these values were expressed as the mg of cholesterol present per kg body weight (mg/kg). It should be noted that these data were derived from the peak on gas-liquid chromatography that co-chromatographed with authentic cholesterol. In extracts from the CNS of newborn mice, a small additional peak corresponding to desmosterol was also usually observed. Thus, in the Results section, the concentration of both cholesterol and desmosterol is given for these newborn animals. 
Cholesterol Synthesis In Vivo
Each animal was injected intraperitoneally with 50 mCi of [ 3 H]water. One hour later, the animals were anesthetized and exsanguinated, and the major tissues were removed and saponified. After isolation of the tissue sterols and quantitation of their 3 H content, the rates of cholesterol synthesis in each tissue were determined and expressed as the nmol of [ 3 H]water incorporated into sterols per hour per g (nmol/hr per g) (49) (50) (51) . The rate of incorporation of [ 3 H]water into sterols by the tissues was converted to an equivalent mg quantity of cholesterol assuming that 0.69 3 H atoms were incorporated into the sterol molecule per carbon atom entering the biosynthetic pathway as acetyl CoA (52) . From such data, the rate of cholesterol synthesis in these mice each day was calculated and these rates were then normalized to a constant body weight of 1 kg (mg/ day per kg).
Tissue Dissection and Morphology
Animals were killed, and brains and spinal cords were removed. In the case of specimens used for biochemical studies, brainstems and cerebella were amputated from the cerebral hemispheres and sectioned in the fresh state in the axial plane. Unfixed cerebral hemispheres were sectioned in the coronal plane. Anatomic landmarks were identified under a dissecting microscope and fresh tissue from appropriate regions, including cerebral cortex, midbrain, cerebellum, brainstem, and spinal cord, was isolated for cholesterol assay.
For morphological studies, fresh brains were immediately placed into 10% neutral, buffered formalin and fixed at room temperature for a minimum of 48 h. Following fixation, the cerebrum from each animal was sectioned in the coronal plane, and the brainstem, cerebellum, and spinal cord in the axial plane. Fixed sections were dehydrated sequentially in graded alcohols and xylene, paraffin embedded, and sectioned for histological study at 4 m. Serial paraffin sections were rehydrated, stained with hematoxylin and eosin (H&E) and with luxol fast blue/PAS/hematoxylin, and evaluated by light microscopy for the presence of neuronal storage material and other structural alterations.
Myelin Protein and Cholesterol Concentration
Brain myelin was isolated by sucrose density gradient centrifugation as described (53) . Brains were weighed and homogenized in 0.32 M sucrose (20 ml/g) and layered over an equal volume of 0.85 M sucrose. After centrifuging at 75,000 ϫ g for 30 min, myelin was collected from the interface. Aliquots of this fraction were saponified, and the cholesterol concentration was determined by gas-liquid chromatography. Myelin protein concentration was also assayed (54) . These data were converted to mg of cholesterol or protein per g wet weight of brain (mg/g).
Calculations
The data from all of these experiments are presented as mean values Ϯ 1 SEM. The Student unpaired t-test was used to compare the various sets of data for significant differences at the p Ͻ 0.05 level.
RESULTS
The phenotypic findings in the NPC mouse are illustrated in Figure 1 . In control, NPC ϩ/ϩ animals at 7 wk of age, the concentration of cholesterol in every tissue, except the CNS and several endocrine glands (not shown), varies from approximately 1.5 to 5 mg/g (A). Nearly all of this sterol is unesterified and is largely found in the plasma membrane of the cells of these tissues. The average concentration of cholesterol in the whole brain is 3-4-fold higher, and this sterol is all unesterified and found in both cell plasma membranes and myelin. In NPC Ϫ/Ϫ animals the concentration of unesterified cholesterol is significantly elevated in nearly every organ, although this increase varies from only 1.3-fold in muscle to 10-fold in liver (B). This sterol is localized in both plasma membranes and intracytoplasmic vesicles. Only in the whole brain is the mean cholesterol concentration significantly lower in the NPC Ϫ/Ϫ mice (13.6 Ϯ 0.1 mg/ g) compared to the control animals (15.0 Ϯ 0.1 mg/g). In these 7-wk-old NPC Ϫ/Ϫ mice there are also striking abnormalities in the neurons of every region of the CNS. As is evident in Figure 2 , vacuolated cytoplasmic storage material is present in virtually all areas of the CNS, including neurons in the cerebral cortex (E), cerebellum (F), brainstem (G), and spinal cord (H).
NEURAL CHOLESTEROL ACCUMULATION IN NPC DISEASE
J Neuropathol Exp Neurol, Vol 59, December, 2000
As shown in Figure 3 , the concentration of cholesterol in the cerebrum and cerebellum of the NPC ϩ/ϩ mice equals about 12 mg/g, but these values rise to almost 30 mg/g in the more heavily myelinated areas of the midbrain, brainstem, and spinal cord (A). As is also apparent, there are significant decreases in the concentration of cholesterol in several of these regions in the NPC Ϫ/Ϫ animals and, importantly, the magnitude of this decrease is proportional to the concentration of cholesterol in that particular region, i.e. the greatest loss of sterol is seen in those regions that have the highest concentrations of myelin-associated cholesterol. Most of these regions also have lower rates of cholesterol synthesis (B).
That the CNS of these 7-wk-old mice has less myelin is further supported by the data in Table 1 . There is a significantly lower concentration of myelin protein (6.8 versus 10.5 mg/g) (A) and myelin cholesterol (3.1 versus 4.9 mg/g) (B) in the NPC Ϫ/Ϫ animals. However, the ratio of cholesterol-to-protein in the remaining myelin is unchanged (C). Taken together, these various results confirm that the lower concentration of cholesterol in the CNS at 7 wk is largely accounted for by less myelinassociated cholesterol and this may have obscured the sequestration of sterol in the cells of the CNS in NPC disease.
In order to investigate this possibility, however, it was necessary to make measurements under circumstances where there is virtually no myelin in the CNS. As illustrated in Figure 4 , the brain of the mouse has a mean concentration of cholesterol equal to only 3.4 Ϯ 0.7 mg/ g at 1 day of age. Myelination occurs rapidly over the next 3 wk, however, and at the end of this time the concentration of sterol in the whole brain exceeds 12 mg/g. For purposes of comparison, this profile of myelination is very different from that seen in an ungulate animal like the sheep where the laying down of myelin cholesterol occurs largely in the last half of gestation so that the newborn is more fully developed and mobile at birth.
Even though relatively little LDL-C has cycled through the coated-pit pathway at 1 day of age, the concentration of cholesterol in every organ of the NPC Ϫ/Ϫ pups is still significantly elevated above that seen in the NPC ϩ/ϩ control animals, as is also shown in Figure 1C , D. Most importantly, however, at this early stage of development where there is virtually no myelination, the concentration of cholesterol in the whole brain is now also significantly elevated (3.82 Ϯ 0.06 versus 3.45 Ϯ 0.07 mg/g) as is the concentration of desmosterol (1.07 Ϯ 0.03 versus 0.90 Ϯ 0.02 mg/g). Furthermore, the magnitude of this elevation is similar to that seen in most of the other organs (D). Not only is this true for the whole brain but as shown in Figure 5 , the concentration of sterol is elevated in every region of the CNS. It should be noted that in the NPC ϩ/ϩ animals, the concentration of cholesterol in these regions in the 1-day-old mice varies between only 3 and 5 mg/ g, values that are well below those seen in the 7-wk-old animals (Fig. 3) . Thus, in the near absence of myelin, the same level of cholesterol elevation seen in the other organs (Fig. 1D) is also seen in all regions of the CNS.
Although these findings establish that cholesterol does accumulate in the CNS in NPC disease, the fact that neurodegeneration and demyelination are occurring simultaneously implies that sterol turnover in the brain must be accelerated in this disorder. Studies were next undertaken to measure this turnover and to compare it to the rate of cholesterol movement through the other organs of the whole animal. As summarized in Table 2 , the turnover of cholesterol acquired from the diet and de novo synthesis is significantly higher in the NPC Ϫ/Ϫ mice (177 mg/ day per kg) than in control animals (128 mg/day per kg) (B). However, since the whole-animal sterol pool is so much larger in the mutant mice (5,460 mg/kg) (A), this daily rate of turnover accounts for only 3.1% of the whole-animal pool in the NPC mice while the control NPC ϩ/ϩ animals turn over 5.5% of their pool each day (C). Between 6 and 8 wk of age, the brains of the control NPC ϩ/ϩ mice accumulate an average of 0.79 mg/day per kg of sterol (F) and synthesize 2.16 mg/day per kg (G). As a consequence, these animals must be losing an average of 1.37 mg of cholesterol per day per kg from the brain (H). During this same time, however, there is actually a net loss of 0.44 mg/day per kg from the sterol pool of the brain of the NPC mice (F) and a significantly lower rate of sterol synthesis (G). As a consequence, the brain of these mutant animals lose significantly more cholesterol each day (2.23 mg/day per kg, H). Thus, the NPC Ϫ/Ϫ mouse is turning over a greater percentage (0.67% per day) of the pool of cholesterol present in cell membranes and myelin of the brain than is the NPC ϩ/ϩ mouse (0.42% per day) (I).
The final experiment explored whether this accumulation of cholesterol in neurons, and the subsequent cell death and apparent loss of myelin, could be ameliorated by interfering with the putative uptake of sterol through a coated-pit pathway in these cells. As the LDLR and apoE are present in the CNS, and as this receptor and ligand are very important in other organs for uptake of cholesterol through the coated-pit pathway, the effect of deleting each of these proteins in the NPC Ϫ/Ϫ mouse on the histological, biochemical, and survival aspects of these animals was investigated. As shown in Figure 6 , there is little difference in the profile of lipoprotein-cholesterol in the NPC ϩ/ϩ (A) and NPC Ϫ/Ϫ (B) animals, although the mutant mice have a slightly elevated concentration of cholesterol carried in both LDL and HDL, as has been reported previously (13, 15 
DISCUSSION
These studies provide the first direct measurements in support of the concept that in NPC disease there is cholesterol accumulation in the cells of the CNS, just as there is in the cells of all other organs of the body (Figs. 1, 5 ) (13, 15) . This accumulation of sterol and other lipids presumably accounts for the perinuclear vesicular inclusions seen in neurons in virtually all regions of the brain and spinal cord (Fig. 2) , and is consistent with the observation that these inclusions fluoresce strongly under ultraviolet light when these tissues are treated with filipin (55). Unlike what happens in other organs, however, this accumulation is apparently associated with death of neurons, loss of myelin, and excretion of excessive amounts of cholesterol from the CNS ( Table 2) . As a consequence, while the cholesterol concentration in virtually every other organ in the body increases with age in this disease (Fig. 1) , the overall concentration of sterol in the CNS actually decreases (Fig. 3) (13) . Nevertheless, these data imply that the same abnormality in intracellular cholesterol transport found in all other organs of the NPC mouse also exists in the cells of the CNS, a conclusion that is further supported by recent studies in isolated neurons from this animal model (56) .
In these other organs, sequestration of unesterified cholesterol is dependent upon the uptake of lipoproteins that contain either apoB-100 or apoE and that utilize the LDLR present in coated pits. A second receptor, LDL related protein (LRP), may also be important as a backup transporter for apoE-containing lipoproteins, particularly when LDLR activity is abrogated (16) (17) (18) . The magnitude of lipoprotein cholesterol uptake through these mechanisms and the rate of unesterified cholesterol sequestration can be altered by manipulating the function of these ligands and receptors. For example, increasing the amount of cholesterol flowing from the intestine to the liver in apoE-containing CMr increases the rate of accumulation of sterol in the liver but not in the other organs of the NPC mice (13) . This effect is seen in the present study even in the 1-day-old NPC pups that had access to cholesterol-rich breast milk for 24 h and, consequently, manifested an exaggerated elevation of hepatic unesterified cholesterol (Fig. 1D) . Deletion of apoE in such animals interferes with this accumulation. Similarly, the rate of cholesterol sequestration in the extrahepatic organs is proportional to the level of LDL-C uptake in these tissues, and this pattern of accumulation can again be altered when LDLR activity is abrogated (15) . However, such sequestration apparently is associated with relatively little cell death, at least up to 7 wk of age, so that the pool of cholesterol in the cells, and in the whole animal, simply increases as a function of age. Thus, the homozygous NPC mouse essentially establishes a new, quasi-steady state where each day about 80 mg of cholesterol per kg body weight is taken up into the tissues through the coated-pit pathway and the pool of unesterified sterol in the whole animal expands by approximately 70 mg/day per kg (34) . Under these conditions, some organs such as the liver begin to manifest functional abnormalities, but most organs apparently function well even though their stores of unesterified cholesterol are expanded.
These experiments indicate, however, that the situation is quite different in the cells of the CNS. Many studies suggest that growth and repair of nerve cells, and their myelination, require a source of cholesterol associated with apoE and receptors such as LDLR and LRP (57) (58) (59) (60) . Thus, while most of the sterol required for development and differentiation of the CNS may come from de novo synthesis, there may also be important internal recycling of cholesterol within the CNS to neurons that requires lipoprotein receptors and takes place through a coated-pit pathway. Presumably, cholesterol taken up through this pathway would become sequestered in the neurons (Fig. 2) , as in all organs outside the CNS, in NPC diseases (Fig. 1) . However, unlike the cells of these other organs that apparently tolerate this stored cholesterol relatively well, neurons in various regions of the CNS begin to die, and there is loss of myelin-associated cholesterol (Table 1) . This leads to a near doubling of the rate of net cholesterol excretion from the CNS ( Table 2 ), so that the average concentration of sterol in the brains of these mice (and humans) with NPC disease actually decreases ( Fig. 3) (3, 14) .
Only recently has the mechanism of this cholesterol excretion been elucidated. Brain expresses a unique cholesterol 24-hydroxylase that apparently converts excess sterol in the CNS to 24S-hydroxycholesterol (61) (62) (63) . This oxysterol can penetrate the blood-brain barrier and appears in the venous outflow from the brain. Utilizing several different methods, it is now possible to calculate this rate of cholesterol excretion in 3 different species. By measuring the net appearance of 24S-hydroxycholesterol in the venous drainage of the brain, the rate of net sterol excretion from the CNS in humans weighing about 70 kg equals ϳ0.09 mg/day per kg (0.02% per day of the pool of cholesterol in the CNS) (64) . Using an isotope exchange method in baboons weighing about 23 kg, this flux rate is found to equal ϳ0.18 mg/day per kg (0.04% per day of the pool) (65) . Direct measurement of the rate of cholesterol excretion from the CNS in mice weighing only 0.021 kg yields a value of ϳ1.37 mg/day per kg (0.42% per day of the pool) ( Table 2) . Thus, the rate of cholesterol excretion from the CNS is a function of animal weight. It should be noted that the rate of sterol turnover in the whole mouse (128 mg/day per kg, Table 2 ) is about 15-fold greater than turnover in the whole human (8-10 mg/day per kg), as is the turnover of cholesterol in the CNS of this species.
One of the important implications to come from these observations is that such measurements in the experimental animal or human may provide a quantitative measure of the rate of neurodegeneration taking place in a particular pathological state. For example, in humans with Alzheimer disease, the plasma concentration of 24S-hydroxycholesterol is elevated 25% and 40%, respectively, above the level found in normal subjects or patients with depression (66) . In NPC disease in the mouse, where the neurodegeneration is more florid (Fig. 2) Ϫ/Ϫ mice (arrows). The absence of either LDLR (C) or apoE (D) had no effect on either the appearance or the distribution of neuronal storage material. H&E, ϫ1,000.
that cholesterol released from dying cells is excreted from the CNS may provide a means for assessing the magnitude of nerve cell death in other neurodegenerative disorders or after trauma.
However, these studies do not provide a measure of the rate of cholesterol recycling among cells within the CNS. The fact that the level of sterol sequestration in the brain and spinal cord of the NPC mice (Fig. 5) is as great as in various organs outside the neuraxis suggests that this recycling is quantitatively substantial. While it is reasonable to assume that this process involves apoE and LDLR, deletion of each of these proteins does not prevent sterol sequestration in the neurons and neurodegeneration (Figs. 7, 8) . The LDLR is important in organs outside the CNS for clearing plasma lipoproteins containing either apoB-100 or apoE. However, abrogation of LDLR activity leads to accumulation of only LDL-C in plasma since LRP readily takes over the function of clearing apoE-containing remnant lipoproteins (Fig. 6C) . Presumably, therefore, LRP or one of the other members of this receptor family are active within the CNS (67) . Failure of deletion of apoE to interfere with this recycling process, however, is less easy to explain since a number of previous experiments indicate that this ligand is important for nerve repair or remodeling (58) (59) (60) . Nevertheless, while an important role for apoE has also been suggested during the repair of peripheral nerves, such repair apparently also occurs normally in animals lacking apoE (68) . Thus, there may be redundancy at this level of the recycling process, both in the peripheral and central nervous systems, that allows some other apolipoprotein to function as a ligand for the uptake process.
In summary, these studies have established that the defect in intracellular cholesterol transport manifest in every other organ also exists in the CNS when NPC1 is mutated. Unlike these other tissues, however, this sequestration of sterol and other lipids leads to nerve cell death, demyelination, and excessive cholesterol excretion from the brain and spinal cord. Deletion of either the LDLR or apoE alone does not alter this process. Clearly, there are at least 2 areas where future studies should be focused that may yield new information on the role of cholesterol movement across and within the CNS in neurodegeneration in NPC disease. First, the experimental means are now available for manipulating the rate of net cholesterol movement across the brain and spinal cord. Second, by developing NPC mice that lack more than 1 lipoprotein ligand or receptor, it may be possible to also manipulate the rate of cholesterol recycling within the CNS. Such studies may yield valuable information on the role of cholesterol in neurodegeneration not only in NPC disease, but also in other degenerative diseases as well.
